sizofiran 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4048 9050-67-3

Description:

MoleculeDescription

Synonyms:

  • sizofilan
  • sizofiran
  • schizophylan
  • schizophyllan
  • schizophyllane
  • shizophyllan
  • sonifilan
A beta-D-glucan obtained from the Aphyllophoral fungus Schizophyllum commune. It is used as an immunoadjuvant in the treatment of neoplasms, especially tumors found in the stomach.
  • Molecular weight:
  • Formula: (C24H40O20)n
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D000276 Adjuvants, Immunologic
MeSH PA D000970 Antineoplastic Agents
MeSH PA D000972 Antineoplastic Agents, Phytogenic
MeSH PA D007155 Immunologic Factors

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01535 KEGG_DRUG
C0036359 UMLSCUI
CHEBI:50653 CHEBI
CHEMBL2107997 ChEMBL_ID
DB13128 DRUGBANK_ID
6107 INN_ID
7F763NNC9X UNII
24777 PUBCHEM_CID
D012566 MESH_DESCRIPTOR_UI

Pharmaceutical products:

None